ADMA News

Pomerantz LLP Advises of Securities Class Action Against ADMA Biologics, Inc. – ADMA

Pomerantz LLP Alerts Shareholders to Investor Suit Against ADMA Biologics, Inc. – ADMA

$ADMA Class Action Lawsuit: The ADMA Biologics Deadline in Securities Fraud Class Action is Approaching on August 10 - Investors Urged to Protect Your Rights

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ADMA

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Securities Class Action Lawsuit Filed Against ADMA Biologics, Inc. (ADMA) – Levi & Korsinsky Represents Shareholders

Securities Lawsuit Alert: ADMA Biologics, Inc. (ADMA) – Contact Levi & Korsinsky Before August 10, 2026

ROSEN, SKILLED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ADMA

Pomerantz LLP Advises Investors of Class Action Involving ADMA Biologics, Inc. – ADMA

$ADMA Stock Loss Notice: ADMA Biologics Investors With Losses Have Rights in Securities Fraud Class Action Lawsuit